Periodic Reporting for period 1 - NEXTER (Next generation eco-friendly, microbiome preserving and reduced resistance therapeutics)

This PoC program was based on our breakthroughs that were accomplished by our ERC-funded project (entitled as "Novel Insights into Multi-drug Resistance to Antibiotics and the Primordial Ribosome-NOVRIB”, Grant Agreement no. 322581). In this PoC project, we extended our...